| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 55.20M | 53.00M | 64.00M | 40.20M | 24.46M |
| Gross Profit | 32.20M | 36.10M | 47.00M | 24.30M | 16.31M |
| EBITDA | 5.90M | -64.10M | 49.40M | 33.80M | 52.93M |
| Net Income | -100.30M | -88.80M | 6.90M | 20.20M | 49.61M |
Balance Sheet | |||||
| Total Assets | 1.18B | 1.27B | 1.44B | 1.72B | 693.60M |
| Cash, Cash Equivalents and Short-Term Investments | 52.50M | 40.50M | 19.90M | 7.60M | 2.69M |
| Total Debt | 376.60M | 448.30M | 481.10M | 703.70M | 22.29M |
| Total Liabilities | 409.10M | 478.30M | 521.50M | 766.20M | 39.51M |
| Stockholders Equity | 761.10M | 788.00M | 912.60M | 951.20M | 654.09M |
Cash Flow | |||||
| Free Cash Flow | 22.70M | 18.30M | 6.40M | 888.90M | -473.92M |
| Operating Cash Flow | 22.70M | 18.30M | 6.40M | 11.10M | 19.96M |
| Investing Cash Flow | 105.00M | 83.90M | 41.50M | -961.90M | -522.47M |
| Financing Cash Flow | -80.70M | -81.60M | -35.60M | 944.10M | 501.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$702.70M | 4.31 | 24.81% | 3.97% | 11.19% | 34.96% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | AU$377.45M | 2.70 | 7.93% | 7.46% | -3.97% | 1057.09% | |
54 Neutral | AU$371.37M | -3.71 | -10.44% | 11.21% | -16.67% | -1419.67% | |
53 Neutral | AU$606.30M | 2.79 | -1.91% | 8.63% | -4.50% | 88.28% | |
52 Neutral | AU$80.88M | -5.93 | -2.01% | 3.95% | -5.21% | -14350.00% | |
49 Neutral | AU$60.00M | -4.82 | -23.55% | 15.14% | -68.24% | 42.03% |
HMC Capital has announced the timetable for releasing half-year financial results to 31 December 2025 for its listed vehicles, including HealthCo Healthcare & Wellness REIT, with a series of result announcements and accompanying investor briefings and webcasts scheduled across February 2026. The structured program of conference calls and webcasts, supported by pre-registration and dedicated investor presentations, signals an organised investor relations push aimed at providing detailed disclosure and engagement with shareholders across HMC Capital’s platform, including the healthcare and wellness real estate portfolio.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$0.80 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT announced updates on its capital management and tenant agreements, emphasizing efforts to maintain financial stability amid ongoing transitional challenges with Healthscope. Healthscope remains compliant with leasing obligations, while HCW proactively prepares to finalize lease agreements with alternative tenants for its hospital assets should the Healthscope sale process not meet terms. Additionally, HCW has implemented strategic asset sales generating $76.8 million in proceeds to ensure adequate liquidity and balance sheet strength. As a further measure to preserve liquidity, HCW will temporarily suspend quarterly distributions until the Healthscope situation is resolved, reflecting their operational focus and financial prudence.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$0.85 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.